Ligne de temps

Gilles Dadaglio
Chercheur(euse) Permanent(e)
17 janv. 2024
project

TRANSLOCK-ER – Sec61 inhibitors for Oncology

Lire plus
01 janv. 2023
publication

Sec61 blockade therapy overrides resistance to proteasome inhibitors and immunomodulatory drugs in multiple myeloma.

Lire plus
07 mars 2022
publication

The Sec61 translocon is a therapeutic vulnerability in multiple myeloma.

Lire plus
11 janv. 2022
news

New publication – The Sec61 translocon is a therapeutic vulnerability in multiple myeloma

Lire plus
08 juin 2018
publication

Mitochondrial reactive oxygen species regulate the induction of CD8+ T cells by plasmacytoid dendritic cells.

Lire plus
01 juin 2018
publication

Tumor-Derived TGFβ Alters the Ability of Plasmacytoid Dendritic Cells to Respond to Innate Immune Signaling.

Lire plus
22 juin 2016
project

Think tank: Cancer

Lire plus
14 mai 2016
publication

B cells promote tumor progression in a mouse model of HPV-mediated cervical cancer

Lire plus
23 nov. 2015
project

Advanced Immunization Technologies (ADITEC)

Lire plus
15 sept. 2015
project

Clinical development of cancer vaccines

Lire plus
07 août 2015
project

Immunity against Mycobacterium ulcerans : the subversive role of mycolactone

Lire plus
15 juin 2015
project

Tumor immunity and preclinical development of cancer vaccines

Lire plus
11 mai 2015
team

Immunobiologie et Thérapie

Lire plus
14 juil. 2014
publication

Antigen targeting to CD11b+ dendritic cells in association with TLR4/TRIF signaling promotes strong CD8+ T cell responses

Lire plus
18 mai 2012
publication

Pivotal role of plasmacytoid dendritic cells in inflammation and NK-cell responses after TLR9 triggering in mice

Lire plus
12 août 2008
publication

Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation

Lire plus
15 mai 2008
publication

Dynamics of immune cell recruitment during West Nile encephalitis and identification of a new CD19+B220-BST-2+ leukocyte population

Lire plus
13 janv. 2006
publication

Purification of splenic dendritic cells induces maturation and capacity to stimulate Th1 response in vivo

Lire plus
27 mai 2004
publication

Murine plasmacytoid dendritic cells induce effector/memory CD8+ T-cell responses in vivo after viral stimulation

Lire plus
01 févr. 2004
publication

New tools for antigen delivery to the MHC class I pathway

Lire plus
01 déc. 2003
publication

Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes

Lire plus
01 mars 2002
publication

Efficient in vivo priming of specific cytotoxic T cell responses by neonatal dendritic cells

Lire plus
01 juin 1997
publication

Potential deleterious effect of anti-viral cytotoxic lymphocyte through the CD95 (FAS/APO-1)-mediated pathway during chronic HIV infection

Lire plus
01 janv. 1997
publication

Limits of the human-PBL-SCID mice model: severe restriction of the V beta T-cell repertoire of engrafted human T cells

Lire plus
15 sept. 1996
publication

Evidence for an in vivo superantigenic activity in human immunodeficiency virus-infected individuals

Lire plus
01 févr. 1994
publication

Selective anergy of V beta 8+ T cells in human immunodeficiency virus-infected individuals

Lire plus
01 juil. 1993
publication

Is a dominant superantigen involved in AIDS pathogenesis?

Lire plus